Related Experiment Video
Updated: Mar 24, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
[CAPNETZ. The competence network for community-acquired pneumonia (CAP)]
Norbert Suttorp1, Tobias Welte2, Reinhard Marre3
1Medizinische Klinik - Infektiologie und Pneumologie, Charité Campus Virchow Klinikum, Campus Mitte und Campus Benjamin Franklin, Augustenburgerplatz 1, 13353, Berlin, Deutschland. norbert.suttorp@charite.de.
The CAPNETZ network has established the world's largest community-acquired pneumonia (CAP) cohort, analyzing over 11,000 patients. This research significantly advanced CAP management through extensive data on epidemiology, diagnostics, and treatment, informing national guidelines.
Area of Science:
- Medical Research
- Infectious Diseases
- Pulmonology
Background:
- CAPNETZ is a German medical competence network focused on community-acquired pneumonia (CAP).
- Funded by the German Ministry for Education and Research, it has 15 years of experience in pneumonia research.
- Established a unique infrastructure enabling the recruitment and analysis of over 11,000 patients.
Purpose of the Study:
- To establish the largest worldwide cohort for community-acquired pneumonia (CAP) research.
- To comprehensively analyze all relevant aspects of CAP management.
- To inform and update national clinical guidelines for CAP.
Main Methods:
- Recruitment and analysis of a large patient cohort (over 11,000 patients).
- Investigation of epidemiology, risk stratification, pathogen spectrum, resistance, and antibiotic management.
- Publication of results in over 150 peer-reviewed journals.
Main Results:
- The CAPNETZ cohort is the largest globally for CAP research.
- Generated extensive data impacting CAP epidemiology, diagnostics, and treatment strategies.
- Results have directly informed the national S3-guideline for CAP management.
Conclusions:
- CAPNETZ has made seminal contributions to pneumonia research over 15 years.
- The network's infrastructure and data form a strong foundation for future research.
- The CAPNETZ foundation is poised for continued success and funding opportunities.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
07:39Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model
Published on: April 6, 2021
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology